Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheelakumari Raghavan

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersRobel K Gebre, Scott A Przybelski, Sheelakumari Raghavan, et al.
Cerebral Circulation - Cognition and Behavior|January 19, 2026
Evaluating regional and global diffusion measures as biomarkers for vascular contributions to cognitive impairment and dementiaSheelakumari Raghavan, Scott A Przybelski, Robert I Reid, et al.
Neurobiology of Aging|September 19, 2022
Blood pressure changes impact corticospinal integrity and downstream gait and balance controlElizabeth A Coon, Anna M Castillo, Timothy G Lesnick, et al.
Research Square|April 1, 2024
Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?Aishwarya Pradeep, Sheelakumari Raghavan, Scott A Przybelski, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 30, 2024
NODDI in gray matter is a sensitive marker of aging and early AD changesXi Yu, Scott A Przybelski, Robert I Reid, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJianqiao Tian, Wen Zhang, Sheelakumari Raghavan, et al.
Alzheimer'S Research & Therapy|August 19, 2025
Evaluation and interpretation of DTI-ALPS, a proposed surrogate marker for glymphatic clearance, in a large population-based sampleSiddhartha Satpathi, Robert I Reid, Scott A Przybelski, et al.
Alzheimer'S Research & Therapy|July 10, 2024
Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?Aishwarya Pradeep, Sheelakumari Raghavan, Scott A Przybelski, et al.
Neurobiology of Aging|October 6, 2020
Reduced fractional anisotropy of the genu of the corpus callosum as a cerebrovascular disease marker and predictor of longitudinal cognition in MCISheelakumari Raghavan, Scott A Przybelski, Robert I Reid, et al.
Brain Communications|June 17, 2021
Diffusion models reveal white matter microstructural changes with ageing, pathology and cognitionSheelakumari Raghavan, Robert I Reid, Scott A Przybelski, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersRobel K Gebre, Scott A Przybelski, Sheelakumari Raghavan, et al.
Cerebral Circulation - Cognition and Behavior|January 19, 2026
Evaluating regional and global diffusion measures as biomarkers for vascular contributions to cognitive impairment and dementiaSheelakumari Raghavan, Scott A Przybelski, Robert I Reid, et al.
Neurobiology of Aging|September 19, 2022
Blood pressure changes impact corticospinal integrity and downstream gait and balance controlElizabeth A Coon, Anna M Castillo, Timothy G Lesnick, et al.
Research Square|April 1, 2024
Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?Aishwarya Pradeep, Sheelakumari Raghavan, Scott A Przybelski, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 30, 2024
NODDI in gray matter is a sensitive marker of aging and early AD changesXi Yu, Scott A Przybelski, Robert I Reid, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJianqiao Tian, Wen Zhang, Sheelakumari Raghavan, et al.
Alzheimer'S Research & Therapy|August 19, 2025
Evaluation and interpretation of DTI-ALPS, a proposed surrogate marker for glymphatic clearance, in a large population-based sampleSiddhartha Satpathi, Robert I Reid, Scott A Przybelski, et al.
Alzheimer'S Research & Therapy|July 10, 2024
Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?Aishwarya Pradeep, Sheelakumari Raghavan, Scott A Przybelski, et al.
Neurobiology of Aging|October 6, 2020
Reduced fractional anisotropy of the genu of the corpus callosum as a cerebrovascular disease marker and predictor of longitudinal cognition in MCISheelakumari Raghavan, Scott A Przybelski, Robert I Reid, et al.
Brain Communications|June 17, 2021
Diffusion models reveal white matter microstructural changes with ageing, pathology and cognitionSheelakumari Raghavan, Robert I Reid, Scott A Przybelski, et al.
Pageof 5